Molecular engineering and validation of an oncolytic herpes simplex virus type 1 transcriptionally targeted to midkine-positive tumors
Intestinal glucose infusion increases portal levels of GLP-1, and coinfusion of exendin-9, a GLP-1R antagonist, abolishes the ability of both intestinal fatty acids and glucose infusion to lower hepatic glucose production 130,131
Gradual tapering under provider guidance minimizes these risks
Strategy 2: Place the effect peak in weekdays Some people have their biggest challenges MondayFriday: long workdays, low energy, spontaneous eating between meetings, or less capacity to make good choices
Providers can send support letters or help patients navigate patient assistance programs
2 GLP-1 (glucagon-like peptide-1) lowers hunger, slows down how quickly the stomach empties, and helps the pancreas release insulin after a meal